Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension

Kim, Nick; D'Armini, Andrea; Grimminger, Friedrich; Gruenig, Ekkehard; Hoeper, Marius; Jansa, Pavel; Mayer, Eckhard; Neurohr, Claus; Simonneau, Gerald; Torbicki, Adam; Wang, Chen; Fritsch, Arno; Davie, Neil; Ghofrani, Hossein-Ardeschir

doi:10.1136/heartjnl-2016-309621

Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension

Kim N. H., D'Armini A. M., Grimminger F., Gruenig E., Hoeper M. M., Jansa P., ...Daha Fazla

HEART, cilt.103, sa.8, ss.599-606, 2017 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 103 Sayı: 8
Basım Tarihi: 2017
Doi Numarası: 10.1136/heartjnl-2016-309621
Dergi Adı: HEART
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.599-606
İstanbul Üniversitesi Adresli: Hayır

Özet

Objective We compared the haemodynamic effects of riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or persistent/recurrent CTEPH after pulmonary endarterectomy in the Chronic Thromboembolic Pulmonary Hypertension Soluble Guanylate CyclaseStimulator Trial 1 study.